Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 1/20 | 0.54 |
| ▸ | TLR8 | Q9NR97 | 3/20 | 0.50 |
| ▸ | HSD17B1 | P14061 | 7/20 | 0.47 |
| ▸ | HSD17B2 | P37059 | 7/20 | 0.47 |
| ▸ | PIM1 | P11309 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | HSD17B14 | Q9BPX1 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 2/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | CTSA | P10619 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5843592 | 0.77 | CYP3A4 (0.50) | ESR2CYP3A4APP | |
| SCHEMBL13678995 | 0.77 | TLR8 (0.70) | ESR2TLR8HSD17B1HSD17B2CYP3A4 | |
| SCHEMBL10091231 | 0.75 | CYP2A6 (0.40) | CYP2D6CYP2C19CTSA | |
| SCHEMBL28767349 | 0.75 | TLR8 (0.58) | ESR2TLR8HSD17B1HSD17B2CYP3A4 | |
| SCHEMBL17725805 | 0.75 | APP (0.61) | ESR2TLR8HSD17B1HSD17B2PIM1 | |
| SCHEMBL10091280 | 0.74 | CHRNA7 (0.40) | CTSA | |
| SCHEMBL10091287 | 0.74 | MEN1 (0.39) | CTSA | |
| SCHEMBL1176399 | 0.74 | TLR8 (0.57) | ESR2TLR8HSD17B1HSD17B2CYP3A4 | |
| SCHEMBL31344492 | 0.74 | TLR8 (0.57) | ESR2TLR8HSD17B1HSD17B2CYP3A4 | |
| SCHEMBL31212447 | 0.74 | TLR8 (0.57) | ESR2TLR8HSD17B1HSD17B2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970353-B1 | MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | VERTEX PHARMA (US) | 2018-04-18 | — | — | EP | disclosed |